Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma
Rory Chan, Kirsten Stewart, Rasads Misirovs, Brian J. Lipworth
Topics & Concepts
MedicineDupilumabExhaled nitric oxideThymic stromal lymphopoietinAsthmaImmunologyOmalizumabImmunoglobulin EMepolizumabExacerbationInterleukin 13CytokineEosinophilInterleukinBronchoconstrictionAntibodyAsthma and respiratory diseasesAllergic Rhinitis and SensitizationIL-33, ST2, and ILC Pathways